Boulding Mark Elliott
Reporting owner on Forms 3, 4 and 5, CIK 1578852.
Boulding Mark Elliott reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-07.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| PTCT · PTC THERAPEUTICS, INC.CIK 1070081 | officer (EXEC. VP AND CLO) | 1 | 2026-10-07 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| PTCT · PTC THERAPEUTICS, INC.Common Stock | 2026-10-06 | M exercised | +435 | $39.42 | 105,707 | Form 4 |
| PTCT · PTC THERAPEUTICS, INC.Common Stock | 2026-10-06 | S sold | -435 | $64.16 | 105,272 | Form 4 |
| PTCT · PTC THERAPEUTICS, INC.Stock Option (Right to Buy), derivative | 2026-10-06 | M exercised | -435 | $0 | 2,459 | Form 4 |
| PTCT · PTC THERAPEUTICS, INC.Common Stock | 2026-10-05 | M exercised | +1,638 | $39.42 | 106,910 | Form 4 |
| PTCT · PTC THERAPEUTICS, INC.Common Stock | 2026-10-05 | S sold | -1,638 | $64.03 | 105,272 | Form 4 |
| PTCT · PTC THERAPEUTICS, INC.Stock Option (Right to Buy), derivative | 2026-10-05 | M exercised | -1,638 | $0 | 2,894 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001578852-26-000024 | PTC THERAPEUTICS, INC. | 2026-10-07 |